AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.2700
+0.0091 (3.49%)
At close: May 18, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $4.34 million as of May 22, 2026. Its market cap has increased by 58.04% in one year.
Market Cap
4.34M
Enterprise Value
4.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 4.34M, a decrease of -78.75%. That is a compound annual growth rate of -30.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 4.34M | -66.81% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 5.78M |
| Reviva Pharmaceuticals Holdings | 5.29M |
| Mosaic ImmunoEngineering | 5.03M |
| Institute of Biomedical Research | 4.67M |
| GPL Holdings | 4.17M |
| Bioxytran | 3.91M |
| Adaptimmune Therapeutics | 3.18M |
| Eastgate Biotech | 3.17M |